Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1594

1.

Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).

Kageyama C, Igawa T, Gion Y, Iwaki N, Tabata T, Tanaka T, Kondo E, Sakai H, Tsuneyama K, Nomoto K, Noguchi H, Yoshino T, Yokota K, Sato Y.

Pathol Int. 2019 Oct;69(10):572-579. doi: 10.1111/pin.12856.

PMID:
31631463
2.

Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.

Lenz HJ, Argiles G, Yoshino T, Lonardi S, Falcone A, Limón ML, Sobrero A, Hastedt C, Peil B, Voss F, Griebsch I, Van Cutsem E.

Clin Colorectal Cancer. 2019 Sep 4. pii: S1533-0028(18)30525-5. doi: 10.1016/j.clcc.2019.08.005. [Epub ahead of print]

3.

Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study.

Takahashi K, Yoshino T, Maki Y, Ishiuchi K, Namiki T, Ogawa-Ochiai K, Minamizawa K, Makino T, Nakamura T, Mimura M, Watanabe K.

Arch Toxicol. 2019 Oct 11. doi: 10.1007/s00204-019-02588-2. [Epub ahead of print]

PMID:
31605160
4.

Catalytic Enantioselective Methylene C(sp3)-H Amidation of 8-Alkylquinolines Using Cp*RhIII/Chiral Carboxylic Acid System.

Fukagawa S, Kojima M, Yoshino T, Matsunaga S.

Angew Chem Int Ed Engl. 2019 Oct 8. doi: 10.1002/anie.201911268. [Epub ahead of print]

PMID:
31593365
5.

Rapid discrimination of fungal species by the colony fingerprinting.

Maeda Y, Sugiyama Y, Lim TK, Harada M, Yoshino T, Matsunaga T, Tanaka T.

Biosens Bioelectron. 2019 Sep 30;146:111747. doi: 10.1016/j.bios.2019.111747. [Epub ahead of print]

PMID:
31586763
6.

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A, Tarpgaard LS, Braun M, Gollerkeri A, Keir C, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J.

N Engl J Med. 2019 Sep 30. doi: 10.1056/NEJMoa1908075. [Epub ahead of print]

PMID:
31566309
7.

Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing.

Fujii S, Yoshino T, Yamazaki K, Muro K, Yamaguchi K, Nishina T, Yuki S, Shinozaki E, Shitara K, Bando H, Mimaki S, Nakai C, Matsushima K, Suzuki Y, Akagi K, Yamanaka T, Nomura S, Esumi H, Sugiyama M, Nishida N, Mizokami M, Koh Y, Abe Y, Ohtsu A, Tsuchihara K.

Biomed Rep. 2019 Oct;11(4):171-180. doi: 10.3892/br.2019.1235. Epub 2019 Aug 21.

8.

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer.

Yoshino T, Kotaka M, Shinozaki K, Touyama T, Manaka D, Matsui T, Ishigure K, Hasegawa J, Inoue K, Munemoto Y, Takagane A, Ishikawa H, Ishida H, Ogata Y, Oba K, Goto K, Sakamoto J, Maehara Y, Ohtsu A.

Cancer Chemother Pharmacol. 2019 Sep 23. doi: 10.1007/s00280-019-03957-5. [Epub ahead of print]

PMID:
31549217
9.

Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.

Hamaguchi T, Denda T, Kudo T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T, Itabashi M, Oki E, Sasaki T, Chiron M, Yoshino T.

Cancer Sci. 2019 Sep 14. doi: 10.1111/cas.14198. [Epub ahead of print]

10.

Differences in demographics and complementary and alternative medicine use between patients attending integrative kampo versus biomedical clinics in Japan.

Melby MK, Yoshino T, Tonob D, Horiba Y, Watanabe K.

Complement Ther Med. 2019 Oct;46:202-209. doi: 10.1016/j.ctim.2019.06.003. Epub 2019 Jun 4.

PMID:
31519280
11.

Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer.

Yaeger R, Kotani D, Mondaca S, Parikh AR, Bando H, Van Seventer EE, Taniguchi H, Zhao H, Thant CN, de Stanchina E, Rosen N, Corcoran RB, Yoshino T, Yao Z, Ebi H.

Clin Cancer Res. 2019 Sep 12. doi: 10.1158/1078-0432.CCR-19-2004. [Epub ahead of print]

PMID:
31515458
12.

Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.

Yoshino T, Yamanaka T, Oki E, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Takeuchi S, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Mizushima T, Saji S, Maehara Y, Ohtsu A, Mori M.

JAMA Oncol. 2019 Sep 12. doi: 10.1001/jamaoncol.2019.2572. [Epub ahead of print]

PMID:
31513248
13.

Feasibility of flow cytometric analysis of restricted light chain in endoscopic biopsy specimens from patients with gastrointestinal tract B cell lymphoma: a pilot study.

Matsueda K, Iwamuro M, Takahashi T, Omote S, Nishida K, Tanaka T, Ennishi D, Otsuka F, Yoshino T, Okada H.

BMC Res Notes. 2019 Sep 11;12(1):571. doi: 10.1186/s13104-019-4578-4.

14.

Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma: Impact on Prognosis and Insights Into Tumorigenesis.

Saijo M, Nakamura K, Ida N, Nasu A, Yoshino T, Masuyama H, Yanai H.

Am J Surg Pathol. 2019 Nov;43(11):1493-1500. doi: 10.1097/PAS.0000000000001353.

PMID:
31478942
15.

Imidate as the Intact Directing Group for the Cobalt-Catalyzed C-H Allylation.

Tanaka R, Tanimoto I, Kojima M, Yoshino T, Matsunaga S.

J Org Chem. 2019 Oct 18;84(20):13203-13210. doi: 10.1021/acs.joc.9b01972. Epub 2019 Sep 6.

PMID:
31449413
16.

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.

Willis J, Lefterova MI, Artyomenko A, Kasi PM, Nakamura Y, Mody K, Catenacci DVT, Fakih M, Barbacioru C, Zhao J, Sikora M, Fairclough SR, Lee H, Kim KM, Kim ST, Kim J, Gavino D, Benavides M, Peled N, Nguyen T, Cusnir M, Eskander RN, Azzi G, Yoshino T, Banks KC, Raymond VM, Lanman RB, Chudova DI, Talasaz A, Kopetz S, Lee J, Odegaard JI.

Clin Cancer Res. 2019 Aug 4. doi: 10.1158/1078-0432.CCR-19-1324. [Epub ahead of print]

PMID:
31383735
17.

Site-Selective Doping and Site-Sensitive Photoluminescence of Eu3+ and Tb3+ in Perovskite-Type LaLuO3.

Ueda K, Tanaka S, Yoshino T, Shimizu Y, Honma T.

Inorg Chem. 2019 Aug 19;58(16):10890-10897. doi: 10.1021/acs.inorgchem.9b01273. Epub 2019 Aug 2.

PMID:
31373798
18.

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.

Kawahara T, Kojima T, Kandori S, Kurobe M, Yoshino T, Kimura T, Nagumo Y, Ishituka R, Mitsuzuka K, Narita S, Kobayashi T, Matsui Y, Ogawa O, Sugimoto M, Miyazaki J, Nishiyama H.

PLoS One. 2019 Aug 1;14(8):e0220173. doi: 10.1371/journal.pone.0220173. eCollection 2019.

19.

HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naïve, HER2-amplified metastatic colorectal cancer.

Nakamura Y, Sawada K, Fujii S, Yoshino T.

ESMO Open. 2019 Jul 8;4(3):e000530. doi: 10.1136/esmoopen-2019-000530. eCollection 2019. No abstract available.

20.

Classification of patients with cold sensation by a review of systems database: A single-centre observational study.

Yoshino T, Katayama K, Yamaguchi R, Imoto S, Miyano S, Mima H, Watanabe K.

Complement Ther Med. 2019 Aug;45:7-13. doi: 10.1016/j.ctim.2019.05.011. Epub 2019 May 11.

PMID:
31331585
21.

Prediction of deficiency-excess pattern in Japanese Kampo medicine: Multi-centre data collection.

Maeda-Minami A, Yoshino T, Katayama K, Horiba Y, Hikiami H, Shimada Y, Namiki T, Tahara E, Minamizawa K, Muramatsu S, Yamaguchi R, Imoto S, Miyano S, Mima H, Mimura M, Nakamura T, Watanabe K.

Complement Ther Med. 2019 Aug;45:228-233. doi: 10.1016/j.ctim.2019.07.003. Epub 2019 Jul 5.

PMID:
31331566
22.

Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer.

Fujiwara M, Akamatsu S, Sumiyoshi T, Segawa T, Mizuno K, Yoshino T, Goto T, Sawada A, Saito R, Kobayashi T, Yamasaki T, Inoue T, Ogawa O.

Clin Genitourin Cancer. 2019 Oct;17(5):e923-e929. doi: 10.1016/j.clgc.2019.04.017. Epub 2019 Jun 12.

PMID:
31307917
23.

Biological responses following one-stage full-mouth scaling and root planing with and without azithromycin: Multicenter randomized trial.

Yashima A, Morozumi T, Yoshie H, Hokari T, Izumi Y, Akizuki T, Mizutani K, Takamatsu H, Minabe M, Miyauchi S, Yoshino T, Tanaka M, Tanaka Y, Gomi K.

J Periodontal Res. 2019 Jul 10. doi: 10.1111/jre.12680. [Epub ahead of print]

PMID:
31292965
24.

Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.

Mishima S, Taniguchi H, Akagi K, Baba E, Fujiwara Y, Hirasawa A, Ikeda M, Maeda O, Muro K, Nishihara H, Nishiyama H, Takano T, Tsuchihara K, Yatabe Y, Kodera Y, Yoshino T.

Int J Clin Oncol. 2019 Jul 8. doi: 10.1007/s10147-019-01498-8. [Epub ahead of print]

PMID:
31286289
25.

Two cases of gastric mucosa-associated lymphoid tissue (MALT) lymphoma masquerading as follicular gastritis.

Iwamuro M, Tanaka T, Nishida K, Kanzaki H, Kawano S, Kawahara Y, Yoshino T, Okada H.

Ecancermedicalscience. 2019 Jun 3;13:933. doi: 10.3332/ecancer.2019.933. eCollection 2019.

26.

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.

Taieb J, Shi Q, Pederson L, Alberts S, Wolmark N, Van Cutsem E, de Gramont A, Kerr R, Grothey A, Lonardi S, Yoshino T, Yothers G, Sinicrope FA, Zaanan A, André T.

Ann Oncol. 2019 Sep 1;30(9):1466-1471. doi: 10.1093/annonc/mdz208.

PMID:
31268130
27.

Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.

Yoshii A, Nagoshi T, Kashiwagi Y, Kimura H, Tanaka Y, Oi Y, Ito K, Yoshino T, Tanaka TD, Yoshimura M.

Cardiovasc Diabetol. 2019 Jul 1;18(1):85. doi: 10.1186/s12933-019-0889-y.

28.

A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects.

Ikeda T, Gion Y, Yoshino T, Sato Y.

J Clin Exp Hematop. 2019;59(2):64-71. doi: 10.3960/jslrt.18039.

29.

[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].

Hattahara K, Yamasaki T, Sawada A, Tanigaki K, Endo S, Teramoto Y, Banno H, Fuchigami Y, Suzuki R, Fujiwara M, Hida T, Yoshino T, Kita Y, Goto T, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.

Hinyokika Kiyo. 2019 May;65(5):157-161. doi: 10.14989/ActaUrolJap_65_5_157. Japanese.

PMID:
31247693
30.

[Retroperitoneal Dedifferentiated Liposarcoma with Metaplastic Bone Formation : A Case Report and Review of the Literature].

Yoshino T, Sejima C, Oka Y, Taniguchi H, Nagami T, Wake K, Yamamoto T, Ohnuma H, Kodama K, Kanazawa A, Kawakami K.

Hinyokika Kiyo. 2019 May;65(5):151-155. doi: 10.14989/ActaUrolJap_65_5_151. Review. Japanese.

PMID:
31247692
31.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum.

Int J Clin Oncol. 2019 Jun 15. doi: 10.1007/s10147-019-01485-z. [Epub ahead of print]

PMID:
31203527
32.

[Hyper-IL-6 syndrome mimicking IgG4-related disease].

Terao T, Yamamoto K, Ikeuchi K, Wakabayashi H, Igawa T, Inoue D, Oda W, Oyama T, Kamoi C, Sumii Y, Shiraishi Y, Yamamoto Y, Niiya D, Shiote Y, Sato Y, Yoshino T, Imajo K.

Rinsho Ketsueki. 2019;60(5):392-397. doi: 10.11406/rinketsu.60.392. Japanese.

PMID:
31168001
33.

Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics.

Abriola L, Hoyer D, Caffrey CR, Williams DL, Yoshino TP, Vermeire JJ.

PLoS One. 2019 Jun 3;14(6):e0217019. doi: 10.1371/journal.pone.0217019. eCollection 2019.

34.

Controlled isoflurane anesthesia exposure is required for reliable behavioral testing in murine surgical models.

Toyama K, Spin JM, Abe Y, Suzuki Y, Deng AC, Wagenhäuser MU, Yoshino T, Mulorz J, Liu S, Tsao PS, Mogi M.

J Pharmacol Sci. 2019 May;140(1):106-108. doi: 10.1016/j.jphs.2019.03.007. Epub 2019 May 11.

35.

Germ cell-less hybrid fish: ideal recipient for spermatogonial transplantation for the rapid production of donor-derived sperm†.

Xu D, Yoshino T, Konishi J, Yoshikawa H, Ino Y, Yazawa R, Dos Santos Nassif Lacerda SM, de França LR, Takeuchi Y.

Biol Reprod. 2019 Aug 1;101(2):492-500. doi: 10.1093/biolre/ioz045.

PMID:
31132090
36.

Risk Factors for Mortality in Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease.

Yoshida A, Kamata N, Yamada A, Yokoyama Y, Omori T, Fujii T, Hayashi R, Kinjo T, Matsui A, Fukata N, Takahashi S, Sakemi R, Ogata N, Ashizuka S, Bamba S, Ooi M, Kanmura S, Endo K, Yoshino T, Tanaka H, Morizane T, Shinzaki S, Kobayashi T.

Inflamm Intest Dis. 2019 Apr;3(4):167-172. doi: 10.1159/000495035. Epub 2019 Feb 6.

37.

Reply by Authors.

Fukunaga A, Kawaguchi T, Funada S, Yoshino T, Tabara Y, Matsuda F, Yoshimura K, Ogawa O, Negoro H; Nagahama Study Group.

J Urol. 2019 Aug;202(2):360-361. doi: 10.1097/01.JU.0000559826.09631.1d. Epub 2019 Jul 8. No abstract available.

PMID:
31095468
38.

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.

Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, Nagata Y, Shiraishi Y, Chiba K, Tanaka H, Zhao L, Ochi Y, Takeuchi Y, Takeda J, Ueno H, Kogure Y, Shiozawa Y, Kakiuchi N, Yoshizato T, Nakagawa MM, Nanya Y, Yoshida K, Makishima H, Sanada M, Sakata-Yanagimoto M, Chiba S, Matsuoka R, Noguchi M, Hiramoto N, Ishikawa T, Kitagawa J, Nakamura N, Tsurumi H, Miyazaki T, Kito Y, Miyano S, Shimoda K, Takeuchi K, Ohshima K, Yoshino T, Ogawa S, Kataoka K.

Leukemia. 2019 May 15. doi: 10.1038/s41375-019-0473-1. [Epub ahead of print]

PMID:
31092896
39.

KRAS mutations in tongue squamous cell carcinoma.

Akagi Y, Tachibana T, Orita Y, Gion Y, Marunaka H, Makino T, Miki K, Akisada N, Yoshino T, Nishizaki K, Sato Y.

Acta Otolaryngol. 2019 Jul;139(7):647-651. doi: 10.1080/00016489.2019.1610574. Epub 2019 May 8.

PMID:
31066593
40.

C-H γ,γ,γ-Trifluoroalkylation of Quinolines via Visible-Light-Induced Sequential Radical Additions.

Kumagai Y, Murakami N, Kamiyama F, Tanaka R, Yoshino T, Kojima M, Matsunaga S.

Org Lett. 2019 May 17;21(10):3600-3605. doi: 10.1021/acs.orglett.9b01015. Epub 2019 May 6.

PMID:
31059277
41.

A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.

Bando H, Kagawa Y, Kato T, Akagi K, Denda T, Nishina T, Komatsu Y, Oki E, Kudo T, Kumamoto H, Yamanaka T, Yoshino T.

Br J Cancer. 2019 May;120(10):982-986. doi: 10.1038/s41416-019-0457-y. Epub 2019 Apr 24.

PMID:
31015557
42.

Cobalt-Catalyzed Allylic Alkylation Enabled by Organophotoredox Catalysis.

Takizawa K, Sekino T, Sato S, Yoshino T, Kojima M, Matsunaga S.

Angew Chem Int Ed Engl. 2019 Jul 1;58(27):9199-9203. doi: 10.1002/anie.201902509. Epub 2019 May 24.

PMID:
30998841
43.

Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.

Satou A, Tabata T, Miyoshi H, Kohno K, Suzuki Y, Yamashita D, Shimada K, Kawasaki T, Sato Y, Yoshino T, Ohshima K, Takahara T, Tsuzuki T, Nakamura S.

Mod Pathol. 2019 Jul;32(8):1135-1146. doi: 10.1038/s41379-019-0264-2. Epub 2019 Apr 5.

PMID:
30952973
44.

Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.

Harada K, Okamoto W, Mimaki S, Kawamoto Y, Bando H, Yamashita R, Yuki S, Yoshino T, Komatsu Y, Ohtsu A, Sakamoto N, Tsuchihara K.

BMC Cancer. 2019 Mar 21;19(1):255. doi: 10.1186/s12885-019-5479-6.

45.

Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.

Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Izumoto H, Ueki H, Tsuruta M, Ono A, Yoshino T, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Kishida M, Tsubouchi E, Abe M, Matsuura B, Ninomiya T, Joko K, Kawasaki H, Hiasa Y, Michitaka K.

Oncology. 2019;96(5):242-251. doi: 10.1159/000496225. Epub 2019 Mar 20.

PMID:
30893698
46.

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study.

Van Cutsem E, Huijberts S, Grothey A, Yaeger R, Cuyle PJ, Elez E, Fakih M, Montagut C, Peeters M, Yoshino T, Wasan H, Desai J, Ciardiello F, Gollerkeri A, Christy-Bittel J, Maharry K, Sandor V, Schellens JHM, Kopetz S, Tabernero J.

J Clin Oncol. 2019 Jun 10;37(17):1460-1469. doi: 10.1200/JCO.18.02459. Epub 2019 Mar 20.

PMID:
30892987
47.

The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis.

Yoshino T, Arita R, Horiba Y, Watanabe K.

BMC Complement Altern Med. 2019 Mar 18;19(1):68. doi: 10.1186/s12906-019-2474-z.

48.

Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study.

Fukunaga A, Kawaguchi T, Funada S, Yoshino T, Tabara Y, Matsuda F, Yoshimura K, Ogawa O, Negoro H; Nagahama Study Group.

J Urol. 2019 Aug;202(2):354. doi: 10.1097/JU.0000000000000212. Epub 2019 Jul 8.

PMID:
30865558
49.

[A Case of Upper Urinary Tract MALT Lymphoma with Remarkable Thickness of Renal Pelvis and Ureter Wall].

Hamada K, Ishitsuka R, Kawai K, Shiga M, Tanaka K, Ikeda A, Yoshino T, Kawahara T, Kandori S, Kimura T, Waku N, Hoshi A, Kojima T, Joraku A, Sato T, Suma S, Sakata M, Obara N, Ito T, Nishiyama H.

Hinyokika Kiyo. 2018 Dec;64(12):489-495. doi: 10.14989/ActaUrolJap_64_12_489. Japanese.

PMID:
30831664
50.

Taming chlorophylls by early eukaryotes underpinned algal interactions and the diversification of the eukaryotes on the oxygenated Earth.

Kashiyama Y, Yokoyama A, Shiratori T, Hess S, Not F, Bachy C, Gutierrez-Rodriguez A, Kawahara J, Suzaki T, Nakazawa M, Ishikawa T, Maruyama M, Wang M, Chen M, Gong Y, Seto K, Kagami M, Hamamoto Y, Honda D, Umetani T, Shihongi A, Kayama M, Matsuda T, Taira J, Yabuki A, Tsuchiya M, Hirakawa Y, Kawaguchi A, Nomura M, Nakamura A, Namba N, Matsumoto M, Tanaka T, Yoshino T, Higuchi R, Yamamoto A, Maruyama T, Yamaguchi A, Uzuka A, Miyagishima S, Tanifuji G, Kawachi M, Kinoshita Y, Tamiaki H.

ISME J. 2019 Aug;13(8):1899-1910. doi: 10.1038/s41396-019-0377-0. Epub 2019 Feb 26.

Supplemental Content

Loading ...
Support Center